Aeglea Biotherapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 71k | 16.76 |
| 2025-06-30 | $1.1M | 73k | 14.97 |
| 2025-03-31 | $904k | 56k | 16.13 |
| 2024-12-31 | $1.3M | 58k | 23.28 |
| 2024-09-30 | $1.6M | 54k | 29.41 |
| 2024-06-30 | $1.2M | 52k | 23.51 |